SCHEMBL26458046

SCHEMBL26458046

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc5c(c4)-c4c(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)cccc4C54c5ccccc5Oc5ccccc54)cc3)n2)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA2B P29275 1/20 0.32
ADORA1 P30542 1/20 0.32
MEN1 O00255 3/20 0.32
MAPT P10636 3/20 0.32
KMT2A Q03164 3/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
LMNA P02545 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GLA P06280 1/20 0.32
PDK2 Q15119 3/20 0.31
HTT P42858 2/20 0.30
APAF1 O14727 1/20 0.30
NPC1 O15118 1/20 0.30
THRB P10828 1/20 0.30
XBP1 P17861 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22216523 1.00 ADORA3 (0.32) ADORA3ALOX15TSHRADORA2AADORA2B
SCHEMBL22216695 1.00 ADORA3 (0.32) ADORA3ALOX15TSHRADORA2AADORA2B
SCHEMBL21426328 1.00 ADORA3 (0.32) ADORA3ALOX15TSHRADORA2AADORA2B
SCHEMBL26457995 0.98 ADORA3 (0.31) ADORA3ALOX15TSHRADORA2AADORA2B
SCHEMBL22216568 0.98 PDK2 (0.31) ADORA3ALOX15TSHRADORA2AADORA2B
SCHEMBL22216531 0.98 ADORA3 (0.31) ADORA3ALOX15TSHRADORA2AADORA2B
SCHEMBL26458097 0.98 ADORA3 (0.31) ADORA3ALOX15TSHRADORA2AADORA2B
SCHEMBL26458236 0.98 ADORA3 (0.32) ADORA3ALOX15TSHRADORA2AADORA2B
SCHEMBL26458014 0.98 ADORA3 (0.32) ADORA3ALOX15TSHRADORA2AADORA2B
SCHEMBL22216765 0.97 PDK2 (0.31) ADORA3ALOX15TSHRADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11641778-B2 Compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11641778-B2 Compound and organic light emitting device comprising same CRY1, CYP1A1, CRY2 ADORA3 3450/4885ALOX15 253/4885TSHR 4342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.